Edwards Lifesciences Debt to Equity Ratio 2011-2025 | EW
Current and historical debt to equity ratio values for Edwards Lifesciences (EW) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Edwards Lifesciences debt/equity for the three months ending September 30, 2025 was 0.06.
| Edwards Lifesciences Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.00B | 0.00 | |
| 2025-06-30 | $2.88B | $10.61B | 0.27 |
| 2025-03-31 | $2.83B | $10.19B | 0.28 |
| 2024-12-31 | $2.99B | $10.06B | 0.30 |
| 2024-09-30 | $3.36B | $9.61B | 0.35 |
| 2024-06-30 | $2.60B | $7.51B | 0.35 |
| 2024-03-31 | $2.55B | $7.19B | 0.36 |
| 2023-12-31 | $2.64B | $6.72B | 0.39 |
| 2023-09-30 | $2.64B | $6.73B | 0.39 |
| 2023-06-30 | $2.56B | $6.45B | 0.40 |
| 2023-03-31 | $2.59B | $6.06B | 0.43 |
| 2022-12-31 | $2.49B | $5.81B | 0.43 |
| 2022-09-30 | $2.42B | $6.22B | 0.39 |
| 2022-06-30 | $2.48B | $5.94B | 0.42 |
| 2022-03-31 | $2.58B | $5.85B | 0.44 |
| 2021-12-31 | $2.67B | $5.84B | 0.46 |
| 2021-09-30 | $2.62B | $5.54B | 0.47 |
| 2021-06-30 | $2.53B | $5.13B | 0.49 |
| 2021-03-31 | $2.56B | $4.66B | 0.55 |
| 2020-12-31 | $2.66B | $4.57B | 0.58 |
| 2020-09-30 | $2.59B | $4.21B | 0.62 |
| 2020-06-30 | $2.59B | $3.84B | 0.67 |
| 2020-03-31 | $2.18B | $3.90B | 0.56 |
| 2019-12-31 | $2.34B | $4.15B | 0.56 |
| 2019-09-30 | $2.15B | $3.82B | 0.56 |
| 2019-06-30 | $2.07B | $3.50B | 0.59 |
| 2019-03-31 | $2.02B | $3.45B | 0.59 |
| 2018-12-31 | $2.18B | $3.14B | 0.70 |
| 2018-09-30 | $2.60B | $3.36B | 0.77 |
| 2018-06-30 | $2.52B | $3.16B | 0.80 |
| 2018-03-31 | $2.58B | $3.25B | 0.80 |
| 2017-12-31 | $2.71B | $2.96B | 0.92 |
| 2017-09-30 | $2.33B | $3.16B | 0.74 |
| 2017-06-30 | $2.20B | $2.94B | 0.75 |
| 2017-03-31 | $2.04B | $2.74B | 0.74 |
| 2016-12-31 | $1.89B | $2.62B | 0.72 |
| 2016-09-30 | $1.65B | $2.69B | 0.61 |
| 2016-06-30 | $1.58B | $2.47B | 0.64 |
| 2016-03-31 | $1.56B | $2.30B | 0.68 |
| 2015-12-31 | $1.55B | $2.50B | 0.62 |
| 2015-09-30 | $1.46B | $2.42B | 0.60 |
| 2015-06-30 | $1.32B | $2.29B | 0.58 |
| 2015-03-31 | $1.28B | $2.21B | 0.58 |
| 2014-12-31 | $1.33B | $2.19B | 0.61 |
| 2014-09-30 | $1.31B | $2.04B | 0.64 |
| 2014-06-30 | $1.41B | $1.92B | 0.74 |
| 2014-03-31 | $1.31B | $1.34B | 0.98 |
| 2013-12-31 | $1.17B | $1.54B | 0.76 |
| 2013-09-30 | $1.09B | $1.44B | 0.76 |
| 2013-06-30 | $0.76B | $1.58B | 0.48 |
| 2013-03-31 | $0.71B | $1.59B | 0.44 |
| 2012-12-31 | $0.74B | $1.48B | 0.50 |
| 2012-09-30 | $0.66B | $1.54B | 0.43 |
| 2012-06-30 | $0.64B | $1.44B | 0.45 |
| 2012-03-31 | $0.61B | $1.39B | 0.44 |
| 2011-12-31 | $0.64B | $1.34B | 0.48 |
| 2011-09-30 | $0.63B | $1.36B | 0.46 |
| 2011-06-30 | $0.62B | $1.39B | 0.45 |
| 2011-03-31 | $0.57B | $1.36B | 0.42 |
| 2010-12-31 | $0.46B | $1.31B | 0.35 |
| 2010-09-30 | $0.49B | $1.23B | 0.40 |
| 2010-06-30 | $0.52B | $1.12B | 0.47 |
| 2010-03-31 | $0.45B | $1.15B | 0.39 |
| 2009-12-31 | $0.46B | $1.16B | 0.40 |
| 2009-09-30 | $0.51B | $1.09B | 0.47 |
| 2009-06-30 | $0.46B | $1.00B | 0.46 |
| 2009-03-31 | $0.42B | $0.94B | 0.44 |
| 2008-12-31 | $0.52B | $0.88B | 0.59 |
| 2008-09-30 | $0.51B | $0.88B | 0.58 |
| 2008-06-30 | $0.45B | $0.90B | 0.50 |
| 2008-03-31 | $0.53B | $0.78B | 0.69 |
| 2007-12-31 | $0.52B | $0.84B | 0.62 |
| 2007-09-30 | $0.48B | $0.82B | 0.58 |
| 2007-06-30 | $0.44B | $0.81B | 0.55 |
| 2007-03-31 | $0.46B | $0.79B | 0.59 |
| 2006-12-31 | $0.50B | $0.75B | 0.66 |
| 2006-09-30 | $0.51B | $0.73B | 0.70 |
| 2006-06-30 | $0.54B | $0.72B | 0.74 |
| 2006-03-31 | $0.52B | $0.72B | 0.71 |
| 2005-12-31 | $0.54B | $0.69B | 0.78 |
| 2005-09-30 | $0.49B | $0.66B | 0.74 |
| 2005-06-30 | $0.49B | $0.66B | 0.74 |
| 2005-03-31 | $0.48B | $0.65B | 0.73 |
| 2004-12-31 | $0.49B | $0.63B | 0.77 |
| 2004-09-30 | $0.47B | $0.60B | 0.79 |
| 2004-06-30 | $0.50B | $0.59B | 0.86 |
| 2004-03-31 | $0.53B | $0.57B | 0.94 |
| 2003-12-31 | $0.47B | $0.64B | 0.73 |
| 2003-09-30 | $0.49B | $0.58B | 0.85 |
| 2003-06-30 | $0.52B | $0.56B | 0.93 |
| 2003-03-31 | $0.49B | $0.54B | 0.91 |
| 2002-12-31 | $0.47B | $0.54B | 0.86 |
| 2002-09-30 | $0.46B | $0.46B | 1.00 |
| 2002-06-30 | $0.50B | $0.48B | 1.05 |
| 2002-03-31 | $0.48B | $0.49B | 0.99 |
| 2001-12-31 | $0.52B | $0.46B | 1.14 |
| 2001-09-30 | $0.55B | $0.41B | 1.33 |
| 2001-06-30 | $0.59B | $0.42B | 1.42 |
| 2001-03-31 | $0.64B | $0.46B | 1.38 |
| 2000-12-31 | $0.67B | $0.44B | 1.52 |
| 2000-09-30 | $0.68B | $0.42B | 1.61 |
| 2000-06-30 | $0.71B | $0.41B | 1.73 |
| 2000-03-31 | $0.70B | $0.68B | 1.02 |
| 1999-12-31 | $0.21B | $1.22B | 0.17 |
| 1999-09-30 | $0.00B | 0.00 | |
| 1999-06-30 | $0.00B | 0.00 | |
| 1999-03-31 | $0.00B | 0.00 | |
| 1998-12-31 | $0.21B | $1.27B | 0.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $49.970B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.960B | 25.90 |
| Intuitive Surgical (ISRG) | United States | $202.722B | 79.31 |
| IDEXX Laboratories (IDXX) | United States | $56.014B | 55.63 |
| Alcon (ALC) | Switzerland | $38.774B | 26.20 |
| IQVIA Holdings (IQV) | United States | $38.071B | 21.23 |
| Mettler-Toledo (MTD) | United States | $28.849B | 33.75 |
| STERIS (STE) | Ireland | $25.561B | 26.39 |
| DexCom (DXCM) | United States | $23.292B | 32.11 |
| Waters (WAT) | United States | $22.582B | 29.87 |
| Hologic (HOLX) | United States | $16.517B | 17.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.201B | 0.00 |
| Globus Medical (GMED) | United States | $11.241B | 23.59 |
| Penumbra (PEN) | United States | $10.916B | 76.79 |
| Masimo (MASI) | United States | $8.188B | 26.24 |
| Sysmex ADR (SSMXY) | Japan | $6.364B | 20.22 |
| Glaukos (GKOS) | United States | $5.273B | 0.00 |
| Teleflex (TFX) | United States | $4.837B | 7.71 |
| TransMedics (TMDX) | United States | $3.949B | 46.78 |
| Veracyte (VCYT) | United States | $3.152B | 35.92 |
| LivaNova (LIVN) | United Kingdom | $3.014B | 16.28 |
| Alphatec Holdings (ATEC) | United States | $3.001B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.384B | 11.19 |
| Artivion (AORT) | United States | $2.160B | 99.11 |
| Elekta AB (EKTAY) | Sweden | $1.775B | 17.20 |
| Nihon Kohden (NHNKY) | Japan | $1.739B | 15.18 |
| PROCEPT BioRobotics (PRCT) | United States | $1.700B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.189B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.155B | 0.00 |
| AxoGen (AXGN) | United States | $1.109B | 0.00 |
| IRadimed (IRMD) | United States | $1.075B | 51.21 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.958B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.749B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.594B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.545B | 10.88 |
| Tactile Systems Technology (TCMD) | United States | $0.544B | 31.65 |
| AngioDynamics (ANGO) | United States | $0.507B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.492B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.441B | 0.00 |
| NeuroPace (NPCE) | United States | $0.427B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.419B | 11.56 |
| RxSight (RXST) | United States | $0.394B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.373B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.349B | 2.63 |
| Alpha Tau Medical (DRTS) | Israel | $0.328B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.65 |
| Spectral Diagnostics (EDTXF) | Canada | $0.255B | 0.00 |
| CVRx (CVRX) | United States | $0.234B | 0.00 |
| 908 Devices (MASS) | United States | $0.210B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.200B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.198B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Neuronetics (STIM) | United States | $0.140B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.134B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| LENSAR (LNSR) | United States | $0.122B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.39 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |